- Home
- CGEN vs SRFM Comparison
CGEN vs SRFM Comparison
Compare CGEN & SRFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGEN
- SRFM
- Stock Information
- Founded
- CGEN 1993
- SRFM 2011
- Country
- CGEN Israel
- SRFM United States
- Employees
- CGEN N/A
- SRFM N/A
- Industry
- CGEN Biotechnology: Biological Products (No Diagnostic Substances)
- SRFM Transportation Services
- Sector
- CGEN Health Care
- SRFM Consumer Discretionary
- Exchange
- CGEN Nasdaq
- SRFM Nasdaq
- Market Cap
- CGEN 167.4M
- SRFM 185.9M
- IPO Year
- CGEN 2000
- SRFM 2023
- Fundamental
- Price
- CGEN $1.45
- SRFM $4.05
- Analyst Decision
- CGEN
- SRFM Buy
- Analyst Count
- CGEN 0
- SRFM 4
- Target Price
- CGEN N/A
- SRFM $5.75
- AVG Volume (30 Days)
- CGEN 206.7K
- SRFM 2.6M
- Earning Date
- CGEN 08-06-2025
- SRFM 08-12-2025
- Dividend Yield
- CGEN N/A
- SRFM N/A
- EPS Growth
- CGEN N/A
- SRFM N/A
- EPS
- CGEN N/A
- SRFM N/A
- Revenue
- CGEN $22,144,000.00
- SRFM $107,372,000.00
- Revenue This Year
- CGEN N/A
- SRFM N/A
- Revenue Next Year
- CGEN $159.40
- SRFM $18.06
- P/E Ratio
- CGEN N/A
- SRFM N/A
- Revenue Growth
- CGEN N/A
- SRFM N/A
- 52 Week Low
- CGEN $1.13
- SRFM $1.02
- 52 Week High
- CGEN $2.66
- SRFM $9.91
- Technical
- Relative Strength Index (RSI)
- CGEN 48.38
- SRFM 44.49
- Support Level
- CGEN $1.39
- SRFM $3.80
- Resistance Level
- CGEN $1.46
- SRFM $4.97
- Average True Range (ATR)
- CGEN 0.06
- SRFM 0.31
- MACD
- CGEN 0.00
- SRFM -0.05
- Stochastic Oscillator
- CGEN 52.63
- SRFM 21.37
About CGEN Compugen Ltd.
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.
About SRFM Surf Air Mobility Inc.
Surf Air Mobility Inc provides a regional air mobility platform to connect communities sustainably. The company is an electric aviation and air travel company expanding the category of regional air travel and reinventing flying through electrification. The company is building a regional air mobility ecosystem to sustainably connect the world's communities. It generates revenue through air mobility services.